Trump's tariff blitz sends markets into overdrive. A 100% levy on imported pharmaceuticals rattled healthcare stocks Friday, with AstraZeneca dropping 4.2% and Novo Nordisk sliding 3.8% as investors digest potential 15% consumer cost spikes. Meanwhile, geopolitical tensions in the Strait of Hormuz pushed crude higher, benefiting energy plays like ExxonMobil and Chevron. The S&P 500 closed nervously as portfolio managers brace for a volatile week ahead. Goldman Sachs warns the policy transition could create significant market disruption despite administration claims of long-term savings. Oil futures spiked 3.1% on supply concerns. Investors face a critical week navigating tariff impacts across pharma, energy, and broader indices.
Post from MarketNews_en
Log in to interact with content.